市場調查報告書
商品編碼
1394056
北美男用保險套市場預測至 2028 年 - 按材料、產品類型和分銷管道進行的區域分析North America Male Condom Market Forecast to 2028 - Regional Analysis By Material, Product Type, and Distribution Channels |
北美男用保險套市場預計將從2022年的19.7953億美元成長到2028年的30.5625億美元。預計2022年至2028年CAGR為7.5%。
北美男用保險套市場性傳染感染病例上升
性傳染感染(STI)對全世界的性健康和生殖健康有重大影響。根據世界衛生組織 (WHO) 的數據,該地區每天有超過 100 萬人感染性傳染感染。每年報告約 3.76 億新感染披衣菌、淋病、梅毒和滴蟲病。避孕方法會改變感染性傳染感染的風險。避孕套可在一定程度上防止細菌和病毒感染。
美國最常見的性傳染感染是人類乳突病毒或 HPV。根據美國國家生物技術資訊中心(NCBI)發表的一篇文章,80%的性活躍族群被感染,其中18-59歲年齡層的人感染率為42%; 7%的人患有口腔HPV;每年報告約 1400 萬新病例。這種情況非常常見,以至於美國疾病管制中心 (CDC) 估計,幾乎所有未接種疫苗的性活躍人士最終都會被感染。 HPV 通常是無症狀的,尤其是男性,但它可能會引起性病和肛門生殖器疣。 CDC 確定 2020 年美國報告了約 240 萬例非 HPV 相關性傳染感染。披衣菌是其中最常見的病例,有 160 萬例。此外,2020年通報淋病病例677,769例,較2016年增加45%;通報第一期及二期梅毒133,945例,較同期增加52%。總體而言,美國性傳染感染的總體發生率正在上升,預計到2022 年將出現250 萬例或更多性傳染感染病例。因此,性傳染感染病例的增加以及政府舉措提高人們對性傳染病的認知將在預測中推動男用安全套市場的發展這段時期正在推動北美男用避孕套市場的成長。
北美男用保險套市場概況
在北美,美國佔有男用保險套市場的重要佔有率。該國市場的成長主要是由於節育意識的增強而推動的。根據美國疾病管制與預防中心2019年美國青少年危險行為調查,最近一次性交時使用保險套的比例為54.3%,保險套是美國最普遍使用的主要避孕措施。
性傳染病的日益普及是該地區市場的主要促進因素。根據美國疾病管制與預防中心 (CDC) 的數據,2018 年,美國五分之一(6,800 萬人)患有 STI(性傳染感染),其中 2018 年新增 STI 病例 2,600 萬例。計劃生育方面的努力可能有利於市場成長。 50多年來,美國政府始終支持計劃生育/生殖健康(FP/RH)工作,是全球計劃生育/生殖健康的最大貢獻者。它是全球最大的避孕藥具分銷商和買家之一。 2019 年,美國政府向聯合國人口基金(UNFPA) 提供的FP/RH 資金為6.08 億美元。美國衛生與公共服務部(HHS) 推出了一項青少年懷孕預防計劃,其中包括針對高風險青少年懷孕群體的計劃。政府為青少年懷孕預防計畫投入了 1 億美元贈款,以解決青少年懷孕和性活動率高的問題,增加避孕措施的使用,減少性傳染感染 (STI) 並增加保險套的使用。
在美國推出的產品數量不斷增加可能會推動預測期內的市場成長。 2022 年,FDA 批准了第一個專門用於肛交的保險套。這種保險套將幫助使用者最大限度地減少肛交過程中的性傳染感染。所有年齡層的需求激增推動了該地區的市場成長。
北美男用保險套市場收入及 2028 年預測(百萬美元)
北美男用保險套市場細分
北美男用保險套市場按產品類型、材料、分銷管道和國家細分。
依產品類型,北美男用保險套市場分為調味保險套、鑲釘保險套、保暖保險套、愉悅保險套等。 2022年,風味細分市場在北美男用保險套市場中佔據最大佔有率。根據材料,北美男用保險套市場分為乳膠和非乳膠。 2022年,乳膠細分市場在北美男用保險套市場中佔據較大佔有率。根據配銷通路,北美男士保險套市場分為藥局/藥局、超市/大賣場、線上藥局等。 2022年,藥局/藥局細分市場在北美男用保險套市場中佔據最大佔有率。根據國家/地區,北美男用保險套市場分為美國、加拿大和墨西哥。 2022年,美國將主導北美男用保險套市場。Reckitt Benckiser Group Plc、Okamoto Industries Inc、Karex Bhd、Church & Dwight Co Inc和Humanwell Healthcare Group Co Ltd是北美男用保險套市場上的一些領先公司。
The North America male condom market is expected to grow from US$ 1,979.53 million in 2022 to US$ 3,056.25 million by 2028. It is estimated to grow at a CAGR of 7.5% from 2022 to 2028.
Rising Cases of Sexually Transmitted Infections in North America Male Condom Market
Sexually transmitted infections (STIs) have a major impact on sexual and reproductive health worldwide. As per the World Health Organization (WHO), more than 1 million people acquire STIs every day regionally. Each year, ~376 million new infections with chlamydia, gonorrhea, syphilis, and trichomoniasis are reported. Contraceptive methods alter the risk of acquiring STIs. Condoms provide a certain level of protection from bacterial and viral infections.
The most common STI in the US is the human papillomavirus or HPV. As per an article published in National Center for Biotechnology Information (NCBI), 80% of sexually active people are infected, including 42% of people in the 18-59 age group; 7% of people have oral HPV; and approximately 14 million new cases are reported yearly. It is so common that the Centers for Disease Control (CDC) estimates that virtually all sexually active persons who are not vaccinated will eventually become infected. HPV is often asymptomatic, especially in men, but it may cause venereal and anogenital warts. The CDC has determined that ~2.4 million non-HPV-related STIs were reported in the US in 2020. Chlamydia was the most common of these at 1.6 million cases. Moreover, 677,769 cases of gonorrhea were reported in 2020, up 45% from 2016, and 133,945 cases of primary and secondary syphilis, up 52% over the same period. In general, the overall rate of STIs is increasing in the US, with 2.5 million STD cases or more expected to occur in 2022. Thus, rising cases of STI's and growing awareness about STDs through government initiatives will drive the market for male condoms in forecast period is driving the growth of the North America Male Condom Market.
North America Male Condom Market Overview
In North America, the US holds a significant share of the male condoms market. The growth of the market in the country is primarily driven by the increasing awareness of birth control. As per the Centers for Diseases Control and Prevention youth risk behavior survey US 2019, the condom use at last sexual intercourse was 54.3%, and condoms were the most prevalent primary contraceptive used in the United States.
The growing prevalence of sexually transmitted diseases is the major driving factor for the market in the region. According to the Centers for Disease Control and Prevention (CDC), in 2018, one in five (68 million) people in the US had an STI (sexually transmitted infection), of which 26 million cases were new STIs in 2018. Also, government efforts for family planning are likely to favor market growth. The government of the US has always supported family planning/reproductive health (FP/RH) efforts for more than 50 years and is the largest contributor to family planning/reproductive health globally. It is one of the largest distributors and buyers of contraceptives worldwide. The US government funds for FP/RH to the United Nations Population Fund (UNFPA) was US$ 608 million in 2019. The Department of Health and Human Services (HHS) introduced a Teen Pregnancy Prevention Initiative comprising programs targeting high-risk teen pregnancy groups. The government invested USD 100 million in grant funding for the Teen Pregnancy Prevention Program to address high rates of teen pregnancy and sexual activity, increase the usage of contraception, reduce sexually transmitted infections (STIs), and increase the use of condoms.
An increasing number of product launches in the US is likely to propel market growth during the forecast period. In 2022, FDA approved the first condom specifically intended for anal sex. This condom will help users to minimize sexually transmitted infections during anal sex. An upsurge in demand among all age groups drives the market growth in this region.
North America Male Condom Market Revenue and Forecast to 2028 (US$ Million)
North America Male Condom Market Segmentation
The North America male condom market is segmented into product type, material, and distribution channels, and country.
Based on product type, the North America male condom market is segmented into flavored condom, studded, warming, pleasured, and others. The flavored segment held the largest share of the North America male condom market in 2022. Based on material, the North America male condom market is segmented into latex and non-latex. The latex segment held a larger share of the North America male condom market in 2022. Based on distribution channel, the North America male condom market is segmented into drug stores/ pharmacies, supermarkets/ hypermarkets, online pharmacies, and others. The drug stores/ pharmacies segment held the largest share of the North America male condom market in 2022. Based on country, the North America male condom market is segmented into the US, Canada, and Mexico. The US dominated the North America male condom market in 2022. Reckitt Benckiser Group Plc, Okamoto Industries Inc, Karex Bhd, Church & Dwight Co Inc, and Humanwell Healthcare Group Co Ltd are some of the leading companies operating in the North America male condom market.